Search results
John Potthoff named CEO of contract research organization RQM+ - Pittsburgh Business Times
The Business Journals· 1 day agoMonroeville-based RQM+ named John Potthoff as its new CEO. Potthoff succeeds Margaret Keegan, who...
Logical Biological Honoured with The King's Award for Enterprise
PRWeb· 7 days ago"We are delighted to receive the King's Award for International Trade, which affirms our role as a...
After fall in demand for COVID-19 tests, San Diego's QuidelOrtho to lay off 500 workers
U-T San Diego· 5 days agoQuidelOrtho, a local diagnostic company that makes at-home COVID-19 test kits, has a new CEO and announced Wednesday that it will cut at least 5 percent of its workforce..
Guardant Health preps for FDA advisory panel review of its blood-based colorectal cancer screening...
FierceBiotech· 1 day agoThe agency has scheduled an advisory panel meeting May 23 to help evaluate the company’s Shield...
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
Fairfield-Suisun Daily Republic· 6 days agoAccelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial preliminary results for the first quarter ended March 31, 2024. In parallel to the ...
QuidelOrtho Corp Reports Mixed Q1 2024 Results Amid Strategic Sh
Guru Focus· 4 days agoThe detailed earnings report can be accessed through the company's 8-K filing. QuidelOrtho Corp, a prominent player in the global in- ...
Maxwell Biosciences Enters Second CRADA with USAMRIID to Test Claromer Compounds as Potential...
Digital Journal· 6 days ago... conducted at USAMRIID leads to vaccines, drugs, diagnostics, and training programs that protect both Warfighters and...our Armed Forces but also is an essential elementin the medical response to any future biological threats that may confront...Maxwell Biosciences is a pre-clinical drug platform...
ProAxsis awarded Innovate UK grant for respiratory monitoring
Medical Device Network via Yahoo Finance· 5 days agoMeanwhile, 41 respiratory assist devices are in development globally, of which 17 are in active...
From Discretion to Regulation: FDA's New Path for LDTs | JD Supra
JD Supra· 7 days agoThe FDA has consistently shown a commitment to regulating LDTs. On May 6, 2024, the new rule that now classifies LDTs as medical devices under the Federal Food, Drug, and Cosmetic Act (FD&C ...
Danaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological...
Morningstar· 6 days agoThe Danaher Beacon for Brain Injury Diagnostics seeks to identify mild Traumatic Brain Injury (TBI) earlier and more precisely. Scientists will evaluate new blood-based biomarkers ...